Susquehanna International Group’s Syneron Medical Ltd ELOS Stock Holding History

Susquehanna International Group’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-22,700	Closed	-$249K	–	10269
2017 Q2	$249K	Sell	22,700 -4,400	-16%	-$48.2K	﹤0.01%	7921
2017 Q1	$286K	Buy	+27,100	New	+$262K	﹤0.01%	7416
2015 Q3	–	Sell	-10,900	Closed	-$116K	–	10652
2015 Q2	$116K	Sell	10,900 -6,300	-37%	-$73.8K	﹤0.01%	9619
2015 Q1	$213K	Buy	+17,200	New	+$190K	﹤0.01%	8546

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Susquehanna International Group's ELOS Position: Q2 2017 in Review

Susquehanna International Group sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 15,350 shares — an estimated $168K sold.

Susquehanna International Group first reported a position in ELOS in Q4 2013 and held it in 2 quarters. The position peaked at $406K in Q4 2013. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

Susquehanna International Group reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
Susquehanna International Group sold 15,350 Syneron Medical Ltd shares in Q2 2017, an estimated $168K.
Susquehanna International Group first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 2 quarters.
Susquehanna International Group's Syneron Medical Ltd position peaked at $406K in Q4 2013.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.